Agenparl
Agenparl English Diritto & Giustizia Salute Social Network

HUMAN MEDICINES EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR): VEYVONDI, VONICOG ALFA, VON WILLEBRAND DISEASES, DATE OF AUTHORISATION: , REVISION: 1, STATUS: AUTHORISED

(AGENPARL) – LONDON (UNITED KINGDOM), ven 27 marzo 2020

Veyvondi is indicated in adults (age 18 and older) with von Willebrand Disease (VWD), when desmopressin (DDAVP) treatment alone is ineffective or not indicated for the
– Treatment of haemorrhage and surgical bleeding
– Prevention of surgical bleeding.

Veyvondi should not be used in the treatment of Haemophilia A.

Fonte/Source: https://www.ema.europa.eu/en/medicines/human/EPAR/veyvondi

Related posts

I NUMERI DEL CONTAGIO IN PAESE AL 29 MARZO

Redazione

IGIENIZZAZIONE DEGLI ARREDI URBANI

Redazione

IL VIAGGIO NEL MONDO DEL NUOVO CORONAVIRUS

Redazione

DETAILED GUIDE: NETHERLANDS: NOTARIAL AND DOCUMENTARY SERVICES

Redazione

CORONAVIRUS: GELMINI, DA VON DER LEYEN PAROLE CHE NON AVREMMO VOLUTO SENTIRE

Redazione

CORONAVIRUS: PETTARIN (FI), SERVE SUBITO CENTRO EUROPEO DI GESTIONE CRISI

Redazione

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More